אלקון אזופט 1% - Alcon azopt 1%
ש××× ×× !
×תר××¤× × ×¢××× ×:×××ר ×תר×פ×ת ×©× ××©×¨× ××ר×××ת.
×× ×תק××× ××××¢× ×¢× ×פסקת ש×××ק ×תר××¤× ×:×ער×ת ×××××¢×ת ×¢× ×פסקת ש×××ק תר×פ×ת.
ת×ר×× ×¢×××× ××ר×× ×תר××¤× ×× ×××ק×תר×פ×ת ××× 14/05/19.
×תר××¤× × ×¢××× ×:×××ר ×תר×פ×ת ×©× ××©×¨× ××ר×××ת.
×× ×תק××× ××××¢× ×¢× ×פסקת ש×××ק ×תר××¤× ×:×ער×ת ×××××¢×ת ×¢× ×פסקת ש×××ק תר×פ×ת.
ת×ר×× ×¢×××× ××ר×× ×תר××¤× ×× ×××ק×תר×פ×ת ××× 14/05/19.
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | S01EC Carbonic anhydrase inhibitors | |||||
|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||
| צ×רת ××ª× | ×¢×× × - OCULAR | |||||
| צ×רת ××× ×× | תר×××£ ××¢××, OPHTHALMIC SUSPENSION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||
| ×ת×××× | Alcon Azopt is indicated to decrease elevated intraocular pressure in: ocular hypertension open-angle glaucoma as monotherapy in patients unresponsive to beta-blockers or in patients in whom beta-blockers are contra-indicated or as adjunctive therapy to beta-blockers.
| |||||
× ×ª×× × ×¡× [ ×צ×× ]
| ||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
××× ×¢××× ×ר××¤× | |||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| [ ××ק×× ×××פ× %1] ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | ALCON COUVREUR, BELGIUM |
| ×©× ××¢× ×ר×ש×× | NOVARTIS ISRAEL LTD |
| ר×ש××× | ת×ר×× ××ש×: 02/1999. ר×ש××× ×ת×ר××: 09/2014 |
| ת×ר×× ×¢×××× ××ר×× | 14/05/19 |